RNU6-1194P

Across TCGA pan-cancer cohorts, RNU6-1194P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-1194P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RNU6-1194P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1194P expression acts as an unfavorable survival marker, although some lineages such as KIRP show a favorable association.

CESC, UCEC, and KIRP are the cancer types where RNU6-1194P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Tertile	II,III,IV	0.144	0.705	.004	72	view →
UCEC	DFS	Tertile	All	0.793	0.899	.030	24	view →
KIRP	DFS	Tertile	All	1.000	0.580	.031	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-1194P–CESC (DFS)

Open the CESC breakdown →